A prospective, multicenter case-control study published in PLoS Medicine in 2025 described the frequency and clinical characteristics of patients with a protracted post-Covid course and searched for risk factors for persistence vs. improvement of symptoms. The analyses showed that in two thirds of the patients who had a post-Covid syndrome 6-12 months after acute SARS-CoV-2 infection, symptoms persisted in the following months.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Urothelial carcinoma
Perioperative innovations and organ-preserving strategies
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- GLA:D® program for back pain patients
Fewer consultations and reduction in the use of painkillers
- Nutrition for type 2 diabetes
Not such a great tuber
- From symptom to diagnosis
Abdominal pain – external hernias
- Mechanisms, evidence and therapeutic consequences
GLP-1 receptor agonists in cardiology
- MASLD/MASH
Drug therapy options on the rise: spectacular evidence
- New ways of neuroregeneration